WHO ICTRP trial
Clinical study of lenalidomide in maintenance therapy of diffuse large B cell…
ChiCTR2100045538 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100045538 |
|---|---|
| Public title | Clinical study of lenalidomide in maintenance therapy of diffuse large B cell lymphoma |
| Scientific title | Clinical study of lenalidomide in maintenance therapy of diffuse large B cell lymphoma |
| Primary sponsor | Affiliated Hospital of Jiangnan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | china |
| Conditions | diffuse large B-cell lymphoma |
| Interventions | 1:lenalidomide |
| Registration date | Apr 19, 2021 |
| Target size | 1:152 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: